The Dairy-Free Trend A Deep Dive into the Growing Lactose-Free Cheese Market and Consumer Shifts Towards Plant-Based Alternatives

According to FMI, the global lactose-free cheese market size is anticipated to reach a US$ 676.3 million valuation by the end of 2022. The market is anticipated to grow between 2022 and 2032 at a CAGR of 8.4%. In 2032, its estimated worth will be US$ 1,515.1 million.

According to FMI, 28% of individuals globally had a dairy sensitivity or allergy in 2020, and roughly 35% were lactose intolerant. We anticipate a rapid increase in these statistics over the course of the study. Furthermore, it is predicted that consumers will favour plant-based foods—such as plant-based protein—over dairy and lactose-containing goods. This has led to an increase in the demand for and consumption of lactose-free cheese worldwide.

Examine Our Sample Report on Animal Welfare and the Growth of Vegan Cheese to Gain a Global Perspective : https://www.futuremarketinsights.com/reports/sample/rep-gb-15623

The treatment of animals is viewed differently in various cultures around the world, including scientific, naturalistic, and moralistic viewpoints. Concerns regarding animal welfare are related to ethical attitudes, but to some extent, humanistic attitudes towards companion animals would also take animal welfare into consideration. As was already indicated, these worries are anticipated to encourage a preference for vegan goods. As a result, different cultures are fueling market expansion for vegan and lactose-free cheese as a whole.

Key Takeaways from Lactose-free Cheese Market Study
• North America lactose-free cheese industry is expected to register 6.8% CAGR between 2022 and 2032.
• Japan lactose-free cheese industry is estimated to grow at 8.6% CAGR between 2022 and 2032.
• India lactose-free cheese industry is projected to exhibit growth at 9.7% CAGR between 2022 and 2032.
• Top 3 countries in the global lactose-free cheese industry are projected to together account for nearly 33.8% of share by 2032.
• During the historical period of 2016 to 2021, the global lactose-free cheese industry exhibited a steady growth at a CAGR of 7.0%.

“For lactose intolerant people, it is nowadays not necessary to completely avoid the indulgence and nutritional value of dairy products. It is further altering the environment for dairy producers across the globe, as they are trying to keep up with changing consumer views. They are further investing in the development of innovative products to cater to the surging demand, which would push the global lactose-free cheese market,” says a lead analyst at FMI.
Key Lactose-free Cheese Manufactures Are Adopting Business to Consumer Models

The importance of business-to-consumer (B2C) models is increasing at a rapid pace in the food and beverage industry, which would further allow producers to get exclusive insights into consumer behavior. When implemented well, this model allows for higher margins to producers. Additionally, growth in B2C has been driven by the fact that buyers are demanding a better experience and customized service.

The B2C model would allow companies to build a direct relationship with the consumer that would not be otherwise possible through other distribution channels. The specialty stores and online retailing segment are helping manufacturers to identify various new upcoming trends and improvise the product according to the consumers’ demand.

Future growth in operations To get the required data, get a bespoke report : https://www.futuremarketinsights.com/customization-available/rep-gb-15623

Competitive Landscape: Lactose-free Cheese Market

Some of the leading companies offering lactose-free cheese are Alpro UK Ltd., Amy’s Kitchen, Inc., Arla Foods Amba, Barry Callebaut AG, Cargill, Inc., Chr. Hansen Holdings A/S, Daiya Foods, Inc., Dean Foods Company, Edlong Dairy Technologies, Emmi AG, Fonterra Co-operative Group Ltd., Galaxy Nutritional Foods, Inc., General Mills, Inc., Green Valley Organics, HP Hood LLC, Land O’Lakes, Inc., Murray Goulburn Co-operative Co. Limited (Devondale Murray Goulburn), Tine AS, WhiteWave Foods Company, and others.

Get More Valuable Insights on Lactose-free Cheese Market

Future Market Insights, in its new offering, provides an unbiased analysis of the lactose-free cheese industry presenting historical demand data (2016-2021) and forecast statistics for the period from 2022-2032. The study divulges compelling insights on the lactose-free cheese market based on product type (blue cheese, brick cheese, camembert cheese, cheddar cheese, cottage cheese, cream cheese, mozzarella cheese, Romano cheese, Swiss cheese), form (cheese blocks, triangle, rectangle, circle, square, cheese slice, cheese spread, and cheese spray), and distribution channel (B2B and B2C [hypermarkets/supermarkets, convenience stores, specialty stores, traditional groceries, and online retailers]) across seven major regions.

Lactose-free Cheese Market Outlook by Category

By Product Type:

  • Blue Cheese
  • Brick Cheese
  • Camembert Cheese
  • Cheddar Cheese
  • Cottage Cheese
  • Cream Cheese
  • Mozzarella Cheese
  • Romano Cheese
  • Swiss Cheese

By Form:

  • Cheese Blocks
  • Triangle
  • Rectangle
  • Circle
  • Square
  • Cheese Slice
  • Cheese Spread
  • Cheese Spray

By Distribution Channel:

  • B2B
  • B2C
    • Hypermarkets/Supermarkets
    • Convenience Stores
    • Specialty Stores
    • Traditional Groceries
    • Online Retailers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle east and Africa

The Insights into the Cheese Market: Consult Our Analysts for a Detailed Examination of Cheese Types, Distribution Routes, and Regional Patterns :
https://www.futuremarketinsights.com/ask-question/rep-gb-15623

Frequently Asked Questions

How big is the lactose-free cheese market?
What is the North America lactose-free cheese industry outlook?
At what rate will the lactose-free cheese industry grow in Europe?
At what rate will the lactose-free cheese industry grow in Japan?
At what rate will the lactose-free cheese industry grow in India?

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

 Contact Us:

Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Microcatheter Industry is poised to attain a US$ 3 billion valuation by 2033, according to FMI’s predictions

The global microcatheters industry demand is poised for substantial growth, with estimations projecting a remarkable surge from its current valuation of US$ 2.1 billion to an anticipated US$ 3 billion by 2033. This forecast underscores the burgeoning opportunities within the microcatheters landscape, fueled by an anticipated average Compound Annual Growth Rate (CAGR) of 3.6% from 2023 to 2033.

Market analysts have highlighted several factors driving this upward trajectory, including technological advancements in healthcare, an increasing preference for minimally invasive procedures, and the expanding applications of microcatheters across diverse medical fields. These miniature catheters have demonstrated significant efficacy in delivering treatments to targeted areas, thereby enhancing patient outcomes while minimizing invasive procedures’ impact.

To Remain Ahead of Your Competitors, Request For A Sample! https://www.futuremarketinsights.com/reports/sample/rep-gb-18099

Minimally invasive procedures are becoming increasingly popular among patients and clinicians due to their many advantages. Microcatheters play a vital role in many minimally invasive procedures.

The global microcatheter market is being driven by a rise in government initiatives to promote better facilities, an increase in strategic collaborations, mergers and acquisitions, a strong product pipeline, and increased microcatheter applications. Nevertheless, the growth of the global microcatheter market is restrained by stringent regulatory requirements and product recalls.

Microcatheters are increasingly utilized in new therapeutic areas, such as neurovascular intervention and oncology. For instance, in neurovascular intervention, microcatheters deliver stents and coils to treat brain aneurysms and other cardiovascular disorders. In oncology, microcatheters are used to provide embolic materials to block blood flow to tumors.

The demand for microcatheters in surgical procedures is being limited due to the increasing awareness of the potential health hazards they pose. Microcatheters are intricate and high-risk due to their small dimensions, making surgical procedures difficult. They are often used in targeted interventions for delicate anatomical structures like blood vessels in the brain or coronary arteries, requiring a high level of precision, which only skilled healthcare professionals possess. The need for experienced professionals in developing and underdeveloped economies is a significant factor that hinders the development of the industry. Additionally, there is an increased risk of accidental dislodgment during surgical interventions, especially when delivering crucial treatments or devices to specific parts of the body.

Market players are heavily investing in developing new and innovative microcatheter products. These new products are designed to improve maneuverability, control, and navigation through complex vasculature.

“The demand for microcatheters is expected to rise due to the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and technological advancements in microcatheter design and development.” – comments an FMI analyst.

Our Analyst Is Available To Help You With Any Inquiries You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-18099

Key Takeaways from the Microcatheter Market:

  • The global microcatheter market is estimated to register a CAGR of 3.6% with a valuation of US$ 3.0 billion by 2033.
  • The market captured a CAGR of 3.4% in the historical period between 2018 and 2022.
  • Japan is anticipated to dominate the global market by registering a 5.0% CAGR during the forecast period.
  • With a 4.3% CAGR, the United Kingdom is driving the global market by 2033.
  • China is anticipated to secure a CAGR of 4.2% in the global market during the forecast period.
  • The United States microcatheter market holds a global market share of 3.8% in 2033.
  • As per the research, South Korea acquired a value share of 2.1% in the global microcatheter market in 2033.

Key Strategies:

Key players in the microcatheter market are investing in research and development to increase their product lines and promote growth. To expand their presence, companies engage in strategic activities like agreements, mergers, and collaborations. One crucial tactic employed by manufacturers is cost-effective production, including local manufacturing. The use of microcatheters offers significant medical benefits, and investment in research and development can improve quality and performance. To remain competitive, manufacturers must prioritize cost-effective solutions.

Elevate Your Brand: Explore the Insights from Our Customization Report! https://www.futuremarketinsights.com/customization-available/rep-gb-18099

Recent Developments in the Microcatheter Market:

  • Merit Medical launched its new Maestro Microcatheter Line in October 2023. The product line includes a longer length for radial embolization procedures, complementing Merit’s radial-first legacy.
  • In Oct 2023, Johns Hopkins University and the University of Maryland developed a soft robotic tool for brain surgeries that enhances surgeons’ maneuverability and streamlines the process.
  • Acotec Scientific Holdings Ltd. received approval for marketing its Vericor-14 microcatheter in China in May 2023.

Key Companies in the Microcatheter Market:

  • Cook Group Incorporated
  • Medtronic Plc
  • Merit Medical Systems, Inc
  • Stryker Corporation
  • Terumo Corporation
  • Boston Scientific Corporation
  • Acotec Scientific Holdings Ltd
  • Penumbra Inc
  • Teleflex Inc
  • Asahi Intecc Co., Ltd

Market Segmentation

By Product Type:

  • Delivery Microcatheters
  • Aspiration Microcatheters
  • Diagnostic Microcatheters
  • Steerable Microcatheters

By End User:

  • Hospitals
  • Surgical Centers
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Application:

  • Cardiovascular
  • Neurovascular
  • Peripheral Vascular
  • Oncological
  • Urological
  • Otolaryngological
  • Other Application

By Cancer Type:

  • Liver Cancer
  • Kidney Cancer
  • Lung Cancer
  • Bone Cancer
  • Other Cancer

By Product Design:

  • Single-Lumen Microcatheters
  • Dual-Lumen Microcatheters

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East & Africa

Gain Immediate Access to Detailed Market Insights: Discount Now! https://www.futuremarketinsights.com/checkout/18099

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Digging Deeper: A Comprehensive Exploration of the Underground Mining Automation Landscape Over the Next Decade

The global Underground Mining Automation market is anticipated to reach US$ 1,418.6 million in 2022 and expand at a CAGR of 5.9% from 2022 to 2032, according to Future Market Insights. The usage of automation solutions in underground mining has expanded due to the quick development of technologies like Artificial Intelligence (AI) and robotics, which can boost production efficiency. Automated underground mining solutions are expanding as a result of the growing trend of using cutting-edge technology.

Technological growth has brought significant changes to the mining industry, which has led to the development of automation solutions, the Internet of Things, data integration technologies, and information management systems. It also paved the way for the development of automation products, solutions, and services used to automate underground mining operations. Additionally, they will improve the productivity, performance, and efficiency of underground mining operations. The main benefits of underground mining automation are improved safety and increased productivity at a lower cost.

Request Sample Report: Empower Your Industry Understanding with Invaluable Insights
https://www.futuremarketinsights.com/reports/sample/rep-gb-10600

The future of underground mining automation hinges on the need to integrate various subsystems into underground mines. Demand for integrated solutions for smarter, safer, and more productive mining will drive the adoption of underground mining automation. Rapidly changing technology in Africa will be a key trend supporting the adoption of underground mining automation.

Underground Mining Automation Market: Market Dynamics

Leading underground mining automation providers are investing in automation to secure a strong future for the mining industry. This factor is expected to drive the global underground mining automation market. Despite trade disputes, demand for metal has supported China and is having a positive impact on the adoption of underground mining automation in global markets. Additionally, growth in telecom solutions will play a major role in increasing the deployment of underground mining automation solutions.

Employee safety and low production rates are key factors driving the adoption of underground mining automation. Additionally, growth in digital mining, digital twins, and other technological innovations have impacted the global underground mining automation market and will continue to grow during the forecast period. The growth of communications in underground mining operations is a key factor determining the adoption of underground mining automation solutions and services.

A major challenge factor for the underground mining automation market is the lack of adoption of the technology among professionals in developing countries. Underground mining automation providers are now taking steps such as offering technology fairs to provide education and awareness.

Underground Mining Automation Market: Regional Outlook

Manufacturers in developed countries such as Germany, the USA, the UK, France, and Japan are leading the way in providing underground mining automation solutions. Mining activity is prominent in countries such as Australia, Russia, China, Canada, Indonesia, South Africa, Peru, Brazil, and other African countries. Currently, miners are focusing on investing in underground mining automation, and the focus is on African countries. Government regulations play an important role in the adoption of underground mining automation systems. However, some countries have implemented stringent regulations to protect the environment, hampering mining activities and negatively impacting the underground mining automation market.

The deployment of underground mining automation solutions will help miners move to unsafe locations and difficult locations in Australia, Brazil and Africa. It is also positive that major mine operators in Ethiopia, Tanzania, Angola, Zambia and Congo are deploying underground mining automation solutions. Impact on the underground mining automation market. New mining projects in countries in Southeast Asia, Latin America, and Africa are expected to drive opportunities in the underground mining automation market.

Underground Mining Automation Market: Key Market Players

The major market players in the global underground mining automation market include:

  • FIG
  • Atlas Copco
  • general electric
  • Glencore
  • hexagon
  • Hitachi
  • Komatsu
  • red pass
  • Rio Tinto
  • Rockwell Automation
  • Sandvik AB
  • Siemens AG

The Underground Mining Automation Market research report presents a comprehensive assessment of the Underground Mining Automation market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using appropriate assumptions and methodologies. The Underground Mining Automation Market research report provides analysis and information according to market segments such as geography, material type, temperature range, and end-use.

Unlock Exclusive Market Segments Insights: Buy Now to Discover Vital Trends, Drivers, and Challenges in this Industry
https://www.futuremarketinsights.com/checkout/10600

Underground Mining Automation Market: Segmentation

The global underground mining automation market can be segmented by type, level of automation, application and end use.

Based on product type, the global underground mining automation market is segmented into:

  • hardware
  • software
  • service

Based on automation level, the global underground mining automation market is segmented into:

  • low-level automation
  • medium level automation
  • fully automated

On the basis of Application, the Global Underground Mining Automation Market is segmented into:

  • loading and transport
  • surface drilling
  • vehicle management
  • tele operation
  • Etc

On the basis of end-use, the global underground mining automation market is segmented into:

  • chrome mining
  • coal mining
  • diamond mining
  • gold mining
  • iron ore mining
  • manganese mining
  • Platinum and Palladium Mining
  • uranium mining
  • Etc

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Pharmacy Automation Industry is projected to achieve US$ 13.3 billion by 2033, with an 8.1% CAGR steering its growth, according to FMI

In 2023, the global pharmacy automation industry growth is expected to be valued US$ 5.6 billion. Companies in a variety of industries are starting to realize how revolutionary the healthcare industry might be. This establishes the foundation for significant expansion, since projections indicate that the market will exceed US$ 13.3 billion by 2033. The market’s outstanding potential over the next ten years is highlighted by the extraordinary CAGR of 8.1% that supports this growth trajectory.

This growth is attributed to a number of factors, including the increasing prevalence of chronic diseases, the rising demand for personalized medicine, and the growing need to improve patient safety and efficiency in pharmacies.

Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-18108

Pharmacy automation can help to improve the accuracy and efficiency of medication dispensing and packaging, as well as reduce the risk of medication errors. They can also help to free up pharmacists’ time so that they can focus on providing more patient-centered care.

Key Takeaways:

  • The global pharmacy automation market is expected to grow from US$ 5.6 billion in 2023 to US$ 13.3 billion by 2033, at a CAGR of 8.1%.
  • The key drivers of the market growth include the rising demand for medication safety, operational efficiency, and technological advancements.
  • The market is segmented by type into automated medication dispensing systems, automated packaging and labeling systems, automated storage and retrieval systems, automated medication compounding systems, and others. The automated medication dispensing systems segment is expected to account for the largest market share during the forecast period.
  • The market is also segmented by application into inpatient pharmacy, outpatient pharmacy, retail pharmacy, and others. The outpatient pharmacy segment is expected to account for the largest market share during the forecast period.
  • North America is expected to be the largest market for pharmacy automation during the forecast period, followed by Europe and Asia Pacific.

Reach Out To Our Analyst For Prompt Assistance With Your Questions! https://www.futuremarketinsights.com/ask-question/rep-gb-18108

Regional Outlook:

  • North America: The North American pharmacy automation market is expected to grow at the fastest CAGR during the forecast period. This is due to the presence of a large number of key players, the high adoption of advanced technologies, and the increasing demand for medication safety and operational efficiency.
  • Europe: The European pharmacy automation market is expected to grow at a moderate CAGR during the forecast period. This is due to the increasing adoption of electronic health records and the growing awareness of the benefits of pharmacy automation.
  • Asia Pacific: The Asia Pacific pharmacy automation market is expected to grow at the second-fastest CAGR during the forecast period. This is due to the growing geriatric population, the rising number of prescriptions, and the increasing investments in healthcare infrastructure.

Other Key Regions: The pharmacy automation markets in South America, the Middle East, and Africa are expected to grow at a slower CAGR during the forecast period. This is due to the limited availability of funds, the lack of awareness of the benefits of pharmacy automation, and the underdeveloped healthcare infrastructure in these regions.

Overall, the pharmacy automation market is expected to grow significantly during the forecast period, driven by the increasing demand for medication safety, operational efficiency, and technological advancements.

Key Companies Profiled in the Pharmacy Automation Market:

  • Becton
  • Cerner Corporation
  • Parata Systems LLC
  • Yuyama Co. Ltd
  • PerceptiMed Inc
  • McKesson Corporation
  • Capsa Solutions LLC
  • Omnicell Inc
  • Dickinson and Company
  • Arxium Inc
  • Scriptpro LLC
  • Swisslog Holdings AG
  • Rxsafe LLC

Discover the Future of Marketing: Get Your Hands on Our Customization Report! https://www.futuremarketinsights.com/customization-available/rep-gb-18108

Key Segments in the Pharmacy Automation Market:

By Product:

  • Medication Dispensing Systems
  • Automated Medication Compounding Systems
  • Packaging and Labeling Systems
  • Storage and Retrieval Systems
  • Tabletop Tablet Counters

By End-use Sector:

  • Inpatient Pharmacies
    • Acute Care Settings
    • Long Term Care Facilities
  • Outpatient Pharmacies
    • Outpatient/Fast Track Clinics
    • Hospital Retail Settings
  • Pharmacy Benefit Management Organization and Mail Order Pharmacies
  • Retail Pharmacies

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Japan
  • Middle East & Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Holter ECG Industry is forecasted to achieve an 8.6% CAGR by 2033, driven primarily by technological advancements and the increasing prevalence of cardiovascular diseases, according to FMI

The global holter ECG industry demand is expected to grow from US$ 645.2 million in 2023 to US$ 1.5 billion by 2033, at a CAGR of 8.6% during the forecast period. The growth of the market is attributed to the increasing prevalence of cardiovascular diseases, rising demand for ambulatory cardiac monitoring, and technological advancements in Holter ECG devices.

A Holter ECG is a non-invasive test that records the electrical activity of the heart over a 24-hour period. It is used to diagnose and monitor heart conditions such as arrhythmias, heart failure, and coronary artery disease.

Discover Our Expert Analysis with Our Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-18077

The primary driver of the growth in the Holter ECG market is the increasing prevalence of arrhythmia and related cardiac and vascular disorders. The primary causes of these illnesses include advanced age, sedentary lifestyles, obesity, and hypertension. The growing prevalence of atrial fibrillation (AF), the associated risk of stroke and cardiovascular diseases, patient awareness of steady ECG recording, and the availability of several efficient ambulatory monitoring devices are all contributing factors to the rising demand for Holter monitors.

Medical professionals anticipate the market for Holter ECG monitors to grow significantly over the course of the forecast period due to a number of factors, such as an increase in the number of elderly people, a rise in the prevalence of cardiovascular diseases, and the growing demand and adoption of these monitors. But the need for more qualified experts who can precisely monitor the Holter ECG reports might be impeding the market’s expansion for Holter ECGs.

Key Trends Driving the Holter ECG Market:

  • Increasing prevalence of cardiovascular diseases: Cardiovascular diseases are the leading cause of death worldwide, accounting for an estimated 17.9 million deaths in 2019. The prevalence of cardiovascular diseases is expected to rise further in the coming years due to aging population, increasing prevalence of obesity and diabetes, and sedentary lifestyles. This is driving the demand for Holter ECG devices for diagnosis and monitoring of cardiovascular diseases.
  • Rising demand for ambulatory cardiac monitoring: Ambulatory cardiac monitoring is a non-invasive diagnostic procedure that allows clinicians to monitor a patient’s heart activity while they are engaged in their daily activities. This is in contrast to traditional ECG monitoring, which is performed in a clinical setting. Ambulatory cardiac monitoring is becoming increasingly popular as it allows clinicians to obtain more accurate and detailed information about a patient’s heart health.
  • Technological advancements in Holter ECG devices: Holter ECG devices are becoming increasingly sophisticated and user-friendly. Newer devices are smaller, lighter, and more comfortable to wear. They also offer a wider range of features, such as the ability to record multiple channels of data, detect arrhythmias, and store data for extended periods of time. These technological advancements are making Holter ECG devices more accessible and attractive to patients and clinicians.

Reach Out To Our Analyst For Prompt Assistance With Your Questions! https://www.futuremarketinsights.com/ask-question/rep-gb-18077

Holter ECG Market Key Takeaways 2023-2033

  • The global Holter ECG market is expected to grow at a CAGR of 8.6% from 2023 to 2033, reaching a valuation of US$ 1.5 billion by 2033.
  • The 12-lead product segment is anticipated to dominate the market, owing to its superior diagnostic capabilities.
  • The ambulatory segment is expected to witness the fastest growth rate during the forecast period, due to the increasing demand for remote monitoring of patients with cardiac conditions.
  • North America is currently the largest market for Holter ECG devices, followed by Europe and Asia Pacific.
  • The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, driven by the rising prevalence of cardiovascular diseases and increasing healthcare spending in the region.

Key Companies in the Holter ECG Market:

  • Royal Philips
  • Nissha Medical Technologies
  • Medtronic PLC
  • Hill-Rom Services Inc.
  • I Rhythm Technologies Inc.
  • AliveCor Inc.
  • Cardiac Insight Inc.
  • Vital Connect
  • Prisma Health
  • BioTelemetry, Inc.

Revolutionizing Customer Engagement: Learn from Our Customization Report! https://www.futuremarketinsights.com/customization-available/rep-gb-18077

Market Segmentation:

By Product Type:

  • 12-Lead
  • 5-Lead
  • 3-Lead
  • 6-lead
  • Single-Lead
  • Others

By Application:

  • Hospitals
  • Clinics
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Spine Pain Industry in the United States is on track to achieve a substantial US$ 10.962.7 million by 2033, at a CAGR of 10.6% | FMI

The spine pain industry analysis in united states is expected to grow at a significant rate in the coming years, driven by a number of factors, including the aging population, rising obesity rates, and increasing prevalence of chronic diseases. According to a report by Future Market Insights, the spine pain industry analysis in united states is expected to grow from US$ 3,962.7 million in 2023 to US$ 10.962.7 million by 2033, at a CAGR of 10.6%.

The Spine Pain Industry Analysis in United States is expected to witness robust growth in the coming years, driven by the increasing prevalence of chronic pain conditions, rising demand for minimally invasive and non-surgical treatment options, and growing geriatric population. Key players in the industry are focusing on developing innovative products and technologies to meet the growing needs of patients.

Get Recently Updated Report of Market as Sample Copy! https://www.futuremarketinsights.com/reports/sample/rep-gb-18051

Key Takeaways:

  • The Spine Pain Industry Analysis in United States is expected to grow at a CAGR of 10.6% from 2023 to 2033, reaching a value of US$ 10,962.7 million by 2033.
  • The spinal non-fusion segment is expected to grow at the fastest CAGR of 10.5% during the forecast period.
  • Increasing prevalence of chronic pain conditions, such as arthritis and osteoporosis, is driving the growth of the spine pain industry.
  • Rising demand for minimally invasive and non-surgical treatment options is also contributing to market growth.

Key Drivers:

The following are some of the key drivers of growth in the US spine pain industry:

  • Aging population: The aging population is a major driver of growth in the spine pain market, as older adults are more likely to experience spine pain due to age-related wear and tear.
  • Rising obesity rates: Obesity is another major risk factor for spine pain. As obesity rates continue to rise in the US, so too will the demand for spine pain treatment.
  • Increasing prevalence of chronic diseases: Many chronic diseases, such as arthritis and osteoporosis, can also lead to spine pain. As the prevalence of these diseases increases, so too will the demand for spine pain treatment.

Reach Out To Our Analyst For Prompt Assistance With Your Questions! https://www.futuremarketinsights.com/ask-question/rep-gb-18051

Key Companies Profiled:

  • Zimmer, Inc. (ZimVie Inc.)
  • Medtronic
  • Johnson & Johnson
  • Stryker Corporation
  • Abbott Laboratories
  • Boston Scientific Corporation
  • B Braun (Aesculap, Inc.)
  • Becton, Dickinson and Company
  • Globus Medical
  • Alphatec Spine, Inc.
  • Nevro Corp
  • NuVasive, Inc.
  • Orthofix US LLC.
  • Surgalign Spine Technologies, Inc.
  • Precision Spine, Inc.

United States Spine Pain Business Outlook by Category:

By Product Type:

  • Spinal Fusion
    • Interbody Devices
    • Pedicle Screw System
    • Spinal Plating System
  • Spinal Non-Fusion
    • Annulus Repair Devices
    • Artificial Disc Replacement Systems
    • Interspinous Process Decompression (IPD) Devices
    • Pedicle Screw-based Dynamic Stabilization Systems
  • Vertebral Body Replacement Systems
  • Spinal Cord Stimulation
  • Transcutaneous Electrical Neuromuscular Stimulation (TENS)
  • Spinal Epidural Injection

By Pain Type:

  • Cervical Pain
    • Arm Pain
  • Thoracolumbar Pain
    • Arm Pain
    • Leg Pain
  • Lumbar Pain
    • Leg Pain
  • Sciatic Pain
    • Leg Pain

By End User:

  • Hospitals
  • Specialty Clinic
  • Ambulatory Surgical Centers

By Region:

  • Northeast
  • Midwest
  • Southeast
  • Southwest
  • West

Innovative Strategies Unveiled: Customization at the Core of Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-18051

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Super Generics Industry in Europe is poised to hit a US$ 14.2 billion valuation by 2033, as forecasted by FMI

The super generics industry analysis in europe for US$ 11.6 billion in 2023 and are predicted to grow to US$ 14.2 billion by 2033. Over the projected period from 2023 to 2033, it is predicted to grow at a CAGR of nearly 2.0%. In terms of value share, the anti-diabetic segment held 13.3%, and in 2022, it led Europe in the drug class category.

The Super Generics Industry Analysis in Europe, also known as improved generics, are generic drugs that offer additional benefits over traditional generics, such as improved delivery systems, reduced side effects, or increased efficacy. They can be developed using new technologies or by improving the formulation or manufacturing process of existing generic drugs.

Get your Sample Report with Latest Market Information! https://www.futuremarketinsights.com/reports/sample/rep-gb-18045

The outlook for the Super Generics Industry Analysis in Europe is positive. The market is expected to grow at a steady pace over the forecast period, driven by increasing demand for affordable and accessible healthcare, growing prevalence of chronic diseases, rising geriatric population, supportive government policies, and technological advancements in the pharmaceutical industry.

However, pharmaceutical companies need to overcome the challenges posed by stringent regulatory requirements, competition from traditional generics, and lack of awareness in order to capitalize on the growth potential of the Super Generics Industry Analysis in Europe.

Key Takeaways – Super Generics Industry Analysis in Europe from 2023 to 2033

  • The Super Generics Industry Analysis in Europe is expected to reach US$14.2 billion by 2033, growing at a CAGR of 2.0% over the forecast period.
  • The anti-diabetic segment is expected to hold the largest market share in terms of value, followed by the cardiovascular and oncology segments.
  • Spain is expected to lead the Super Generics Industry Analysis in Europe, followed by France, Poland, and Germany.
  • Key drivers of the market growth include increasing government support for generic drugs, rising demand for affordable healthcare, and growing prevalence of chronic diseases.
  • Key challenges to the market growth include complex regulatory environment and stringent intellectual property laws.

Get In Touch With Our Analyst To Resolve Any Doubts You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-18045

Key Trends in the Super Generics Industry Analysis in Europe:

Some of the key trends driving the growth of the Super Generics Industry Analysis in Europe include:

  • Increasing focus on research and development: Pharmaceutical companies are investing heavily in research and development to develop new and innovative super generics.
  • Growing adoption of biosimilars: Biosimilars are a type of super generic that are similar to biologic drugs. They are gaining popularity in Europe due to their lower cost and comparable efficacy.
  • Expansion of the super generics portfolio: Pharmaceutical companies are expanding their super generics portfolio to include a wider range of therapeutic areas.
  • Government support: Governments in Europe are supporting the growth of the super generics market through various initiatives, such as tax breaks and subsidies.

Key Companies Profiled:

  • AbbVie
  • Sun Pharmaceutical Industries Ltd.
  • Endo International
  • Viatris Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Innovida Pharmaceutique
  • SERB Specialty Pharmaceuticals
  • Eagle Pharma
  • Novartis AG

Ignite Innovation with Customization: Uncover the Possibilities in Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-18045

Key Segments Covered in the Europe Super Generics Space:

By Drug Class:

  • Antihistamines
  • Antimicrotubule Agents
  • Aryl Acetic Acid Derivatives
  • Atypical Antipsychotics
  • Anti-diabetic
  • Anti-Obesity Drugs
  • Calcium Channel Blockers
  • Corticosteroids
  • Fabric Acid Agents
  • GABA Analogs
  • Opioid Analgesics
  • Proton Pump Inhibitors
  • Retinoids
  • Others

By Route of Administration:

  • Oral
  • Topical
  • Parenteral
  • Others

By Indication:

  • Oncology
  • Cardiology
  • Diabetics
  • Neurology
    • Migraine
    • Epilepsy
    • Alzheimer
    • Pain Management
  • Gastroenterology
  • Dermatology
  • Analgesics & Anti-inflammatory
  • Weight Management
  • Ophthalmology
  • Others

By Distribution Channel:

  • Hospital
  • Specialty Clinics
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies/ Mail Order Pharmacies

By Region:

  • Western Europe
  • Eastern Europe
  • Rest of Europe

Gain Immediate Access to Detailed Market Insights: Discount Now! https://www.futuremarketinsights.com/checkout/18045

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global CO2 Injector Industry is expected to achieve US$ 21,520.3 Thousand by 2033, driven by a 6.2% CAGR, according to FMI’s forecast

The global CO2 injector industry demand is projected to grow at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2033, the global CO2 injector market is projected to increase from US$ 11,756.2 thousand in 2023, according to Future Market Insights (FMI). The market is expected to reach a valuation of US$ 21,520.3 thousand by 2033.

The growth of the CO2 injector market is primarily driven by the increasing demand for minimally invasive procedures, rising investments in healthcare infrastructure, and technological advancements. CO2 injectors are widely used in a variety of medical procedures, such as laparoscopy, arthroscopy, and hysteroscopy. These procedures offer several advantages over traditional open surgeries, such as reduced pain, shorter hospital stays, and faster recovery times.

Get your Sample Report with Latest Market Information! https://www.futuremarketinsights.com/reports/sample/rep-gb-18012

Another key growth driver for the CO2 injector market is the increasing prevalence of chronic diseases, such as obesity, diabetes, and cancer. These diseases often require minimally invasive procedures for diagnosis and treatment. CO2 injectors play a vital role in these procedures by providing a safe and effective way to deliver carbon dioxide gas into the body.

In addition, technological advancements in CO2 injector design and manufacturing are also contributing to the growth of the market. For example, the development of automated CO2 injection systems has made the procedures more precise and efficient. This has led to increased adoption of CO2 injectors in hospitals and clinics.

Key Trends in the CO2 Injector Market:

  • Increasing demand for minimally invasive procedures: Minimally invasive procedures are gaining popularity due to their several advantages over traditional open surgeries. CO2 injectors are widely used in these procedures, which is driving the growth of the market.
  • Rising investments in healthcare infrastructure: Governments and private investors are increasingly investing in healthcare infrastructure. This is leading to the establishment of new hospitals and clinics, which is creating new opportunities for CO2 injector manufacturers.
  • Technological advancements: Technological advancements in CO2 injector design and manufacturing are making the procedures more precise and efficient. This is leading to increased adoption of CO2 injectors in hospitals and clinics.

Get In Touch With Our Analyst To Resolve Any Doubts You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-18012

Key Takeaways: CO2 Injector Market from 2023 to 2033

  • The global CO2 injector market is projected to grow at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2033, reaching a value of US$ 21,520.3 thousand by the end of the forecast period.
  • The increasing demand for minimally invasive procedures, growing prevalence of chronic diseases, and rising investments in healthcare infrastructure are driving the growth of the market.
  • North America is expected to remain the dominant market for CO2 injectors during the forecast period, followed by Europe and Asia Pacific.
  • The automated CO2 injection system segment is projected to retain its dominance in the market throughout the forecast period.

Regional Outlook:

North America is expected to remain the largest market for CO2 injectors, followed by Europe and Asia Pacific. The high demand for minimally invasive procedures and the presence of major CO2 injector manufacturers in the region are driving the growth of the North American market.

The European market is also expected to witness significant growth during the forecast period. This is attributed to the increasing prevalence of chronic diseases and the rising investments in healthcare infrastructure in the region.

The Asia Pacific market is also expected to grow at a rapid pace during the forecast period. This is due to the growing population, the increasing prevalence of chronic diseases, and the rising demand for minimally invasive procedures in the region.

Key Companies Profiled in CO2 Injector Market:

  • Angiodroid
  • Malek Medical GmbH
  • Optimed

Step into the Age of Customization: Unraveling Trends in Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-18012

CO2 Injector Market Outlook by Category:

By Product:

  • Automated
  • Semi-automated

By Application:

  • Peripheral Angiography
  • Interventional Radiology
  • Vascular Surgery
  • Interventional Cardiology

By End User:

  • Hospitals
  • Independent Cath Laboratories

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Fish Meal Alternatives: Riding the Wave of Veganism with a 7.10% CAGR Market Insights and Growth Opportunities

The fish meal alternative market iis expected to experience steady growth, with a projected CAGR of 7.10% between 2023 and 2033. The market is estimated to be valued at US$ 1,924.2 million in 2023, with an anticipated increase to US$ 3,674.0 million by 2033. This growth is attributed to the increasing adoption of healthier, vegan eating habits, driven by environmental and health benefits. Consumers are turning to alternatives to fish meals to align with plant-based diets, aiming to replace conventional animal-based dietary items.

The fish meal alternative market is projected to witness an average growth momentum in the global market at a CAGR of 7.10% during 2023 and 2033. The market share is estimated to be valued at US$ 1,924.2 million in 2023 and is anticipated to reach US$ 3,674.0 million by 2033.

Due to the many advantages for both the environment and human health, consumers are progressively adopting healthier, vegan eating habits. Alternatives to fish meals are gaining popularity as a means of achieving broad societal acceptance and being included in diets devoid of animal products.

The primary goal of the expanding vegan movement is to replace conventional animal-based dietary items with a variety of substitutes, primarily plant-based equivalents. The rising consumption of fish and seafood has a detrimental influence on aquaculture as well as the natural ecosystem. The traditional techniques of marine farming, the dwindling biodiversity and severe environmental effects increase the intoxication level of fish and other aquatic organisms. This promotes a business strategy by manufacturers to shift towards plant-based substitutes for fish and seafood that have the same texture, flavour, and nutritional content as the real thing.

Gain Access to This Report’s Brochure @
https://www.futuremarketinsights.com/reports/brochure/rep-gb-6088

Fish Meal Alternative Market: Segmentation

Technological advancements have brought various methods of structuring the stimulation of the nanometric fibrous-gel structure of fish and seafood, using techniques such as hydro spinning, extrusion and 3D printing.

Scaling up production and developing an efficient cost-effective supply chain to compete with the traditional fish feed, which has been operating the market as a dominant threat for a longer time is a real challenge for fish meal alternative market players. Moreover, the lack of awareness and acceptance perspective in consumers about newer and unconventional alternative sources of proteins derived from plants or insects comes as a barrier in the development of the fish feed alternative market. Consumers may be hesitant to make a shift from traditional options.

In the realm of alternative fish meal and seafood, the manufacturers have several growth opportunities as the market is particularly booming and rapidly moving from niche to more mainstream requirements. The producers have the benefit of exploiting the consumers interest in the rising awareness about ethical practices and environmental impacts of industrial fishery.

Market Scenario

  • The rapid surge in the vegan population in North America has boosted the market growth in several countries. The United States held a global market value of 20.1% dominating the global market for fish meal alternatives.
  • The fish meal alternative market in Germany is valued at 7.6% shares of the global market. This rise can be attributed to the rising consumer awareness of the importance of eating healthy food and the rise in health concerns.
  • Over the projection period, the fish meal alternative market in India is likely to see a rise in demand with a CAGR of 3.4%. The developments in technology and availability of more realistic alternatives with a higher nutritional value in the global market leads the producers to invest more in emerging economies such as India.
  • The fish meal alternative market will increase with a CAGR of 5.3% in the United Kingdom because of the significant optimism about animal activism and welfare.

Use promo code ->> FMITODAY to get flat 20% discount

  • because of the significant optimism about animal activism and welfare.

Competiton among Key Players

FMI identified Archer Daniels Midland, Angel Yeast Co. Ltd, Cargill Corporation, Lallemand Inc., Alltech and Nutreco N.V as the major players in the fish feed alternative market. These players are continuously working towards developing strategies to launch new products and innovate new techniques to diversify their customer base.

The market is expected to attract many investments from both established players and startups in the forecast period. Market players are aiming to expand their market presence by adopting strategies such as partnerships, collaborations, acquisitions and mergers to increase their revenue share.

Recent Developments

  • Lallemand, aiming to accelerate research and development in the field of fermented foods, gets involved in the committee of Grand Défi Ferments du Futur Programme in December 2022.
  • In May 2023, Archer Daniels Midland (ADM), announced the acquisition of DCA Finance BV, to extend the geographical footprint of ADMIS to provide risk management for consumers. This agreement is expected to be completed by the second half of 2023.

Talk to the Analyst for this Report@
https://www.futuremarketinsights.com/ask-question/rep-gb-6088

Key Segments of Fish Meal Alternative Industry Survey

Type:

  • Organic
  • Conventional

Source:

  • Plant
  • Peas
  • Lupins
  • Corn
  • Rice
  • Canola
  • Rapeseed
  • Barley
  • Wheat
  • Animal
  • Micro-organism

By Application:

  • Feed
  • poultry
  • livestock
  • pet food
  • Treats
  • Fertilizers
  • Pharmaceuticals
  • Dietary

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

 Contact Us:

Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Submucosal Lifting Agent Industry is projected to touch US$ 222.6 Million by 2033, spurred by ongoing advancements in endoscopic technologies | FMI

Over the estimated timeframe, a compound annual growth rate (CAGR) of 6.9% is anticipated for the global submucosal lifting agent industry growth. According to projections, the market value will rise from US$ 114.2 million in 2023 to US$ 222.6 million by 2033. The global market is expected to expand by 6.8% year over year in 2023, from its end-of-year valuation of US$ 106.9 million in 2022.

A submucosal lifting agent is a substance used in medical procedures to create a separation between the mucous membrane and underlying tissue. It is injected into the submucosal layer to facilitate endoscopic procedures, improving visibility and maneuverability. Sodium hyaluronate, cellulose, absorbable starch polymers, and poloxamers are commonly employed as submucosal lifting agents due to their biocompatibility and ability to create a temporary cushion, enhancing the endoscopic process.

Get Recently Updated Report of Market as Sample Copy! https://www.futuremarketinsights.com/reports/sample/rep-gb-17913

In the healthcare landscape, the demand for minimally invasive procedures is driving the growth of the submucosal lifting agent market. Procedures involving submucosal lifting agents, such as the removal of polyps, adenomas, and early-stage cancers, are gaining popularity due to their reduced invasiveness and quicker recovery times. The rising incidence of gastrointestinal disorders, coupled with advancements in endoscopic technologies, further amplifies the market’s expansion.

As awareness of these procedures increases and medical professionals embrace safer and efficient techniques, the submucosal lifting agent market is poised for substantial growth in the coming years. The versatility of agents like sodium hyaluronate, cellulose, absorbable starch polymers, and poloxamers, coupled with their applicability in diverse conditions, contributes to the upward trajectory of the market. In an era where patient comfort, reduced risks, and enhanced procedural outcomes are paramount, the market for submucosal lifting agents is set to thrive, catering to both medical professionals’ and patients’ evolving needs.

Key Takeaways from Market Study:

  • By ingredients, sodium hyaluronate segment contributed around US$ 30.4 million in 2022. Sodium hyaluronate, a natural glycosaminoglycan, aids wound healing, inflammation, and cell interactions, making it vital in submucosal lifting agents.
  • By application, early-stage cancer contributed around US$ 34.9 million in 2022. Submucosal lifting agents aid in endoscopic resection of early-stage gastrointestinal cancers, cushioning lesions and reducing procedure times for effective removal.
  • By end user, hospitals contributed around US$ 39.5 million in 2022. Due to the demand for surgical procedures and the use of sophisticated medical facilities, hospitals dominate the market for submucosal lifting agent.
  • By region, North America held the dominant share in the world in 2022 contributing around US$ 44.6 million. The North America region dominates the submucosal lifting agent market due to advanced healthcare infrastructure and high adoption rates.

“The market for precise, minimally invasive endoscopic operations is being shaped by cutting-edge developments in submucosal lifting agents” says an analyst of Future Market Insights.

In Case Of Any Queries, Don’t Hesitate To Contact Our Analyst! https://www.futuremarketinsights.com/ask-question/rep-gb-17913

Market Competition:

Steris and Ovesco Endoscopy AG are two of the key players leading in the postoperative panniculus retractor market. In order to gain a larger market share, these companies participate in acquisitions and launch new products that provide affordability, convenience, and effectiveness.

  • In May 2023, Ovesco Endoscopy AG has acquired distribution from Fides Medical BV, allowing Ovesco to sell products directly in Belgium and Luxemburg from June 2023. This move aligns with Ovesco’s strategy to match Fides’ high-quality service to local hospitals, while also fulfilling corporate responsibility.
  • In April 2023, Steris’ ASCENDO™ Submucosal Lifting Agent offers quality endoscopic lift, optimal height and duration, and a prefilled syringe for easy, safe resection procedures. It is biocompatible and sterile, making it a convenient and effective solution for endoscopic procedures.

Elevate Your Brand: Explore the Insights from Our Customization Report! https://www.futuremarketinsights.com/customization-available/rep-gb-17913

Key Companies Profiled:

  • Laborie
  • STERIS
  • Olympus America
  • Medtronic
  • Boston Scientific Corporation
  • Omnimed Ltd™
  • COSMO PHARMACEUTICALS
  • Micro-Tech Endoscopy
  • Ovesco Endoscopy AG

Key Market Segments Covered in Submucosal Lifting Agent Industry Research:

By Ingredient:

  • Poloxamer 188 and Polyoxyl-15-hydroxystearate
  • Gellan gum and Polysaccharide
  • Sodium Hyaluronate
  • Cellulose
  • Absorbable Starch Polymers
  • Poloxamers

By Application:

  • Polyps
  • Adenomas
  • Early-stage Cancers
  • Gastrointestinal Mucosal Lesions
  • Others

By End User:

  • Hospitals
  • Specialty Clinics
  • Surgical Centers
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube